scholarly article | Q13442814 |
P2093 | author name string | Gene Hung | |
Xiankui Li | |||
Lan Kluwe | |||
David Lim | |||
Johng S Rhim | |||
William Slattery | |||
Rodolfo Faudoa | |||
Zhu Xeu | |||
P4510 | describes a project that uses | HEI193 | Q54882275 |
P433 | issue | 3 | |
P921 | main subject | cell line | Q21014462 |
P304 | page(s) | 475-482 | |
P577 | publication date | 2002-03-01 | |
P1433 | published in | International Journal of Oncology | Q6051527 |
P1476 | title | Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2 | |
P478 | volume | 20 |
Q30471189 | A novel imaging-compatible sciatic nerve schwannoma model |
Q30388655 | Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors. |
Q33622690 | Comprehensive pharmacological profiling of neurofibromatosis cell lines |
Q30406342 | Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2. |
Q36880469 | Delivery of Therapeutic Proteins via Extracellular Vesicles: Review and Potential Treatments for Parkinson's Disease, Glioma, and Schwannoma. |
Q39610985 | Enhanced in vivo imaging of metabolically biotinylated cell surface reporters |
Q38770088 | Extracellular vesicles derived from human vestibular schwannomas associated with poor hearing damage cochlear cells |
Q39293667 | Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth |
Q40126901 | Imaging and therapy of experimental schwannomas using HSV amplicon vector-encoding apoptotic protein under Schwann cell promoter |
Q35047921 | Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis |
Q28728224 | Investigation of the in vitro therapeutic efficacy of nilotinib in immortalized human NF2-null vestibular schwannoma cells |
Q39444934 | LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2. |
Q35836025 | Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism |
Q28648056 | Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf/Raf-1 complex and inhibition by the NF2 tumor suppressor protein. |
Q36445494 | Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity |
Q91713132 | Polo-like kinase 1 as a therapeutic target for malignant peripheral nerve sheath tumors (MPNST) and schwannomas |
Q30377885 | Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth. |
Q34062012 | Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas |
Q34055933 | R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis |
Q33795121 | Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models. |
Q36634951 | Regression of schwannomas induced by adeno-associated virus-mediated delivery of caspase-1. |
Q24301750 | Regulation of mixed lineage kinase 3 is required for Neurofibromatosis-2-mediated growth suppression in human cancer |
Q30428483 | miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways |
Q30401833 | p75NTR is highly expressed in vestibular schwannomas and promotes cell survival by activating nuclear transcription factor κB. |
Q54882275 | HEI193 | described by source | P1343 |
Search more.